CTSH Stock Forecast & Price Target

Cognizant Tech Solns is attractive because its AI-tailwinds portfolio, roughly 40% of revenue, is growing 2-3x faster than total organic services revenue, while more than 50% of software development is now AI-assisted, supporting stronger productivity and revenue per associate. Financial Services is already proving the model with three consecutive quarters of double-digit growth and historic-high bookings, and the company also posted 3Q26 revenue of $5,664m, adjusted operating margin of 16.3%, and adjusted EPS of $1.49, all above expectations. The outlook is further reinforced by Project Leap, which targets about $200m of 2026 savings against $180m to $250m of costs, plus a 4Q26 exit rate of roughly 2% organic constant-currency growth that suggests durable momentum despite uneven demand across the rest of the portfolio.

Cognizant Tech Solns is facing a deteriorating fundamental backdrop as FY26 constant-currency revenue growth guidance was cut to 4.0%-4.4% from 4.0%-5.5%, while 4Q26 implies a further slowdown to 3.2%-4.7% versus 4.8% in 3Q. Management’s near-term support from Financial Services and North America is being offset by weaker healthcare enrollment work, softer third-party product sales, and macro pressure on discretionary spending in healthcare and consumer-facing sectors, limiting confidence in sustained acceleration. On top of that, regulatory risk from PERM scrutiny threatens the firm’s offshore labor-arbitrage model, while the downside scenario already assumes a deceleration in growth and a failure to convert its deal pipeline into profitable revenues.